Fact CheckerSign in

NCT07116096Recruiting

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Source: ClinicalTrials.gov · Last updated 15 Sept 2026

Brief summary (registry, in English)

1. Background Handgrip strength , a core indicator of muscle function, has been confirmed to be significantly associated with the clinical prognosis of patients with liver cirrhosis. However, no studies have explored its correlation with portal venous hemodynamics. 2. Objective The purpose of the study is to examine the effects of Handgrip strength on portal vein and left gastric vein pressure, blood flow velocity and direction in patients with liver cirrhosis, as well as its hemodynamic impact on gastroesophageal varices. 3. Method Study Design: Interventional study. Detection Timing: Hemodynamic indices were measured simultaneously after patients achieved their maximum handgrip strength. Participants were divided into three groups based on the assessment methods. Group 1 (Portal Pressure Measurement Group): Before the placement of TIPS, the pressures of the portal vein and left gastric vein were measured, both before and after the handgrip strength test. Group 2 (Doppler Ultrasound Measurement Group): Measurements of portal flow velocity and direction were taken before and after the handgrip strength test, based on Doppler ultrasound. Group 3 (Endoscopic Ultrasound Measurement Group): Measurements of blood flow volume and direction in esophagogastric varices were conducted before and after the handgrip strength test, based on endoscopic ultrasonography. The inclusion and exclusion criteria were described. 4. Elaboration of the Research Hypothesis 4.1. Core Hypothesis The handgrip strength level in patients with liver cirrhosis is correlated with portal venous system hemodynamic indices. Specifically, enhanced handgrip strength may affect portal hypertension and the hemodynamics of varicose veins by improving systemic muscle function or circulatory status. 4.2. Speculation on potential mechanisms Association between muscle function and circulation: As a representative of systemic muscle function, increased handgrip strength may reflect an increase in cardiac output or changes in splanchnic vascular resistance, thereby influencing portal venous hemodynamics. Effects on varicose veins: Improved handgrip strength may reduce blood flow velocity or diameter of esophagogastric varices by decreasing splanchnic congestion or regulating local vascular tension, thus lowering the risk of variceal rupture and bleeding. Role of compensatory mechanisms: Muscle wasting is common in decompensated cirrhosis. Patients with higher handgrip strength may have better compensatory capacity, and the degree of hemodynamic disorder in their portal venous system may be less severe. Conclusion This study uses a multi-method grouping design to first explore the association between handgrip strength and portal venous hemodynamics in cirrhotic patients. The hypothesis is based on the potential regulatory role of muscle function in the circulatory system, which is expected to provide a new non-invasive indicator for clinical assessment of portal hypertension risk.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
28 Jul 2025
Start date
17 Aug 2025
Primary completion date
15 Aug 2027
Lead sponsor
Shanxi Provincial People's Hospital
NCT number
NCT07116096

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 17 Aug 2025 to the primary completion date, 15 Aug 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants who had undergone hand or wrist surgery within the previous 3 months or were unable to hold the dynamometer with the testing hand were excluded from the study.

Other illness

  • Severe congestive heart failure, or severe untreated valvular heart disease
  • Moderate to severe pulmonary hypertension
  • Uncontrolled systemic infection
  • No gastrointestinal bleeding (suitable for the ultrasound examination group and the endoscopic ultrasonography group)

Lab values

  • INR \> 5
  • Platelet count \< 20 ×109/mm3

Other

  • Lesions (e.g., cysts) or tumors in the liver parenchyma that preclude TIPS creation
  • Overt hepatic encephalopathy
  • Unrelieved biliary obstruction
  • Child-Pugh score \> 13
  • MELD score \> 18

Who the study is looking for

  • Adults aged ≥18 years old
  • Clinically diagnosed with liver cirrhosis
  • Endoscopic observation to determine the presence of esophagogastric varices
  • Only eligible for the portal vein pressure measurement group if there are no signs of variceal bleeding for at least 14 days
  • Participant or guardian is capable of comprehending the study protocol, willing to participate, and able to provide written informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated Hospital of Henan University of Science and Technology
Coordinator of this site? Confirm its status
LuoyangChinaRecruiting
Shanxi Provincial People's Hospital
Coordinator of this site? Confirm its status
TaiyuanChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.